BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 446390)

  • 1. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients.
    Schusdziarra V; Harris V; Arimura A; Unger RH
    Endocrinology; 1979 Jun; 104(6):1705-8. PubMed ID: 446390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
    Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
    Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs.
    Schusdziarra V; Rouiller D; Harris V; Pfeiffer EF; Unger RH
    Regul Pept; 1980 Oct; 1(2):89-96. PubMed ID: 6114514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal.
    Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF
    Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Somatostatin-like immunoreactivity in chemically sympathectomized dogs.
    Schusdziarra V; Rouiller D; Harris V; Dey R; Unger RH
    Horm Metab Res; 1980 Dec; 12(12):656-60. PubMed ID: 6110628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-casomorphins on somatostatin release in dogs.
    Schusdziarra V; Schick R; de la Fuente A; Holland A; Brantl V; Pfeiffer EF
    Endocrinology; 1983 Jun; 112(6):1948-51. PubMed ID: 6133741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis.
    Trevisani F; Bernardi M; Grilli F; De Palma R; Piazzi S; Patrono D; Gasbarrini G
    Am J Gastroenterol; 1988 Jun; 83(6):646-51. PubMed ID: 2897785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis.
    Schusdziarra V; Zyznar E; Rouiller D; Boden G; Brown JC; Arimura A; Unger RH
    Science; 1980 Feb; 207(4430):530-2. PubMed ID: 7352262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
    Rümenapf G; Hanisch E; Schwille PO
    Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral glucose and protein load on plasma glucagon and insulin concentrations in small for gestational age infants.
    Salle BL; Ruiton-Ugliengo A
    Pediatr Res; 1977 Feb; 11(2):108-12. PubMed ID: 840499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.